Moberg Derma AB (STO: MOB) has hired Lena Pereswetoff-Morath as Vice President Pharmaceutical Innovation & Development. Lena comes from a similar position at Orexo and has extensive experience in drug development, e.g. from Biolipox and AstraZeneca.
"We have seen strong sales growth for Nalox™ and the additional contracts and product launches create opportunities for international expansion and continued growth. Lena brings valuable experience to the organization in the expansion phase. I am happy to welcome Lena to the team”, says Peter Wolpert, President and CEO of Moberg Derma.